Home » Topics » BioWorld

BioWorld
RSS

PATENT FLASH

Nov. 22, 1991

NABI ACQUIRES BIOLOGICALS BUSINESS

Nov. 22, 1991

ONCOR LICENSES POTENTIAL TUMOR SUPPRESSOR

Nov. 21, 1991

GENELABS GETS PATENT FOR HTLV-I DIAGNOSTIC

Nov. 21, 1991

U.S. BIO STOCK CONTINUES TO RISE

Nov. 21, 1991

ALZA TO DEVELOP GENERICS WITH AHP

Nov. 21, 1991

IMMULOGIC, MMD DEAL FOR ALLERGY DRUGS

Nov. 21, 1991

RIBI TEST IMPROVES PROGNOSES

Nov. 21, 1991

CELLPRO TO EXPAND CEPRATE TRIALS

Nov. 20, 1991

VIMRX TO EXPAND AIDS DRUG TRIALS

Nov. 20, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...